Publication | Closed Access

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

HypertensionActive Comparator StudyCardiovascular DiseaseAntihypertensive AgentsAntihypertensive TherapyPharmacologyCardiovascular PharmacologyAngiotensin Ii ReceptorPharmacotherapyMedicineBlood PressureBlood-pressure Reduction